DK1598346T3 - Fremgangsmåde til fremstilling af syreadduktsalt af polysyreholdig baseforbindelse - Google Patents
Fremgangsmåde til fremstilling af syreadduktsalt af polysyreholdig baseforbindelseInfo
- Publication number
- DK1598346T3 DK1598346T3 DK04715495.0T DK04715495T DK1598346T3 DK 1598346 T3 DK1598346 T3 DK 1598346T3 DK 04715495 T DK04715495 T DK 04715495T DK 1598346 T3 DK1598346 T3 DK 1598346T3
- Authority
- DK
- Denmark
- Prior art keywords
- acid
- polyo
- substant
- procedure
- preparing
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 6
- 150000003839 salts Chemical class 0.000 title abstract 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 4
- 150000007514 bases Chemical class 0.000 abstract 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003052700 | 2003-02-28 | ||
| PCT/JP2004/002375 WO2004076441A1 (ja) | 2003-02-28 | 2004-02-27 | 多酸性塩基化合物の酸付加塩の製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1598346T3 true DK1598346T3 (da) | 2012-05-29 |
Family
ID=32923406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04715495.0T DK1598346T3 (da) | 2003-02-28 | 2004-02-27 | Fremgangsmåde til fremstilling af syreadduktsalt af polysyreholdig baseforbindelse |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US7750150B2 (da) |
| EP (1) | EP1598346B1 (da) |
| JP (2) | JP4594863B2 (da) |
| KR (1) | KR101106127B1 (da) |
| CN (2) | CN1753886B (da) |
| AT (1) | ATE554083T1 (da) |
| AU (1) | AU2004215523B2 (da) |
| BR (1) | BRPI0407908A (da) |
| CA (1) | CA2516822C (da) |
| DK (1) | DK1598346T3 (da) |
| EA (1) | EA009045B1 (da) |
| ES (1) | ES2384517T3 (da) |
| IL (1) | IL170093A (da) |
| IS (1) | IS7978A (da) |
| MX (1) | MXPA05009129A (da) |
| MY (1) | MY140618A (da) |
| NO (1) | NO331272B1 (da) |
| NZ (1) | NZ541716A (da) |
| PL (1) | PL378292A1 (da) |
| TW (2) | TWI374136B (da) |
| WO (1) | WO2004076441A1 (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI324600B (en) * | 2003-07-07 | 2010-05-11 | Kowa Co | 2,4-bis (trifluoroethoxy) pyridine compound and drug containing the compound |
| JPWO2005020996A1 (ja) * | 2003-08-29 | 2007-11-01 | 興和株式会社 | リピド・リッチ・プラークの安定化方法及び破裂予防方法 |
| TW200619204A (en) * | 2004-12-10 | 2006-06-16 | Kowa Co | Method for reduction, stabilization and prevention of rupture of lipid rich plaque |
| AU2006285915B2 (en) * | 2005-08-30 | 2011-02-24 | Asahi Kasei Pharma Corporation | Sulfonamide compound |
| US8415372B2 (en) * | 2007-02-27 | 2013-04-09 | Asahi Kasei Pharma Corporation | Sulfonamide compound |
| CN101622243B (zh) * | 2007-02-28 | 2013-12-04 | 旭化成制药株式会社 | 磺酰胺衍生物 |
| JP5234825B2 (ja) | 2007-07-02 | 2013-07-10 | 旭化成ファーマ株式会社 | スルホンアミド化合物及びその結晶 |
| WO2009068755A1 (en) * | 2007-11-30 | 2009-06-04 | Braggone Oy | Novel siloxane polymer compositions |
| US20130035344A1 (en) * | 2009-12-29 | 2013-02-07 | Kowa Co., Ltd. | Pharmaceutical composition for oral administration |
| US20120289517A1 (en) * | 2009-12-29 | 2012-11-15 | Kowa Co., Ltd. | Solid pharmaceutical composition for oral administration |
| CA2798735A1 (en) * | 2010-05-19 | 2011-11-24 | Haruki Shibata | Prophylactic and/or therapeutic agent for non-alcoholic steatohepatitis |
| US9777028B2 (en) * | 2015-06-17 | 2017-10-03 | Gilead Sciences, Inc. | Co-crystals, salts and solid forms of tenofovir alafenamide |
| JPWO2018092765A1 (ja) * | 2016-11-15 | 2019-10-17 | 学校法人同志社 | 経鼻投与用医薬組成物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL112152A (en) * | 1994-12-26 | 2000-11-21 | Identa Ltd | Process and test kit for cocaine detection |
| US6969711B2 (en) * | 1997-05-26 | 2005-11-29 | Kowa Company, Ltd. | Cyclic diamine compounds and medicine containing the same |
| PT987254E (pt) * | 1997-05-26 | 2005-04-29 | Kowa Co | Compostos de diamina ciclica, originais, e medicamentos que os contem |
| GB9826180D0 (en) | 1998-11-30 | 1999-01-20 | Smithkline Beecham Plc | Novel process |
| US20060165605A1 (en) * | 2001-12-28 | 2006-07-27 | Ye-Mon Chen | Process to regenerate fcc spent catalyst |
| JP4745666B2 (ja) * | 2002-12-12 | 2011-08-10 | 興和株式会社 | ヒドロキシアルキル環状ジアミン化合物 |
| TWI324600B (en) * | 2003-07-07 | 2010-05-11 | Kowa Co | 2,4-bis (trifluoroethoxy) pyridine compound and drug containing the compound |
-
2004
- 2004-02-25 MY MYPI20040608A patent/MY140618A/en unknown
- 2004-02-27 BR BRPI0407908-6A patent/BRPI0407908A/pt not_active Application Discontinuation
- 2004-02-27 CN CN2004800052621A patent/CN1753886B/zh not_active Expired - Fee Related
- 2004-02-27 CN CN201210189482.0A patent/CN102702171B/zh not_active Expired - Fee Related
- 2004-02-27 DK DK04715495.0T patent/DK1598346T3/da active
- 2004-02-27 TW TW100135167A patent/TWI374136B/zh not_active IP Right Cessation
- 2004-02-27 AT AT04715495T patent/ATE554083T1/de active
- 2004-02-27 NZ NZ541716A patent/NZ541716A/en not_active IP Right Cessation
- 2004-02-27 WO PCT/JP2004/002375 patent/WO2004076441A1/ja active Search and Examination
- 2004-02-27 JP JP2005502951A patent/JP4594863B2/ja not_active Expired - Fee Related
- 2004-02-27 ES ES04715495T patent/ES2384517T3/es not_active Expired - Lifetime
- 2004-02-27 AU AU2004215523A patent/AU2004215523B2/en not_active Ceased
- 2004-02-27 PL PL378292A patent/PL378292A1/pl not_active IP Right Cessation
- 2004-02-27 EP EP04715495A patent/EP1598346B1/en not_active Expired - Lifetime
- 2004-02-27 MX MXPA05009129A patent/MXPA05009129A/es active IP Right Grant
- 2004-02-27 EA EA200501379A patent/EA009045B1/ru not_active IP Right Cessation
- 2004-02-27 CA CA2516822A patent/CA2516822C/en not_active Expired - Fee Related
- 2004-02-27 US US10/545,200 patent/US7750150B2/en not_active Expired - Fee Related
- 2004-02-27 TW TW093105174A patent/TWI355384B/zh not_active IP Right Cessation
- 2004-02-27 KR KR1020057015048A patent/KR101106127B1/ko not_active IP Right Cessation
-
2005
- 2005-08-04 IL IL170093A patent/IL170093A/en not_active IP Right Cessation
- 2005-08-12 IS IS7978A patent/IS7978A/is unknown
- 2005-09-02 NO NO20054100A patent/NO331272B1/no not_active IP Right Cessation
-
2010
- 2010-04-16 US US12/762,111 patent/US8518936B2/en not_active Expired - Fee Related
- 2010-07-15 JP JP2010160354A patent/JP5180998B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20054100D0 (no) | Fremgangsmate for fremstilling av syreaddisjonssalter | |
| DE602004024545D1 (de) | Indungen | |
| EA200970569A1 (ru) | Применимые в качестве гербицидных соединений пиридопиразиновые производные | |
| EA201070607A1 (ru) | Гербицидные соединения | |
| EA200901638A1 (ru) | Способ получения 2,6-диэтил-4-метилфенилуксусной кислоты | |
| NO20071880L (no) | Diagnostic Compounds | |
| EP2662352A3 (en) | Method for Producing Phenylacetamide Compound | |
| BRPI0514543A (pt) | sais de metanossulfonato de abiraterona-3-ésteres e recuperação de sais de abiraterona-3-ésteres de solução em éter de terc-butila de metila | |
| BRPI0516911A (pt) | método para a preparação de um composto e composto de anilina | |
| DK1633697T3 (da) | Fremgangsmåde til fremstilling af substituerede 3-aryl-butyl-aminforbindelser | |
| DK1678119T3 (da) | Fremgangsmåde til fremstilling af 2-dihalogenacyl-3-amino-acrylsyreestere og 3-dihalogenmethyl-pyrazol-4-carboxylsyreestere | |
| EA200870321A1 (ru) | Способ получения 4-оксохинолинового соединения | |
| EA200800324A1 (ru) | Новый способ получения солей тиотропия | |
| UA93869C2 (en) | Method for preparing pyrazoles | |
| DE602006014001D1 (de) | Herstellung von 2-aminothiazol-5-carbonsäurederivaten | |
| FR2890959B1 (fr) | Procede de preparation d'une composition de platre. | |
| EA201001252A1 (ru) | Способ получения производных 3,6-дигидро-1,3,5-триазина | |
| ATE517904T1 (de) | Ionische flüssigkeiten mit fluoralkyltriffluorborat-anionen | |
| NO20053208D0 (no) | Metode for reduktiv dehalogenering. | |
| DK1558560T3 (da) | Fremgangsmåde til fremstilling af 2,6-dihalogen-para-trifluormenthylanilin | |
| ATE489368T1 (de) | Pyrimidinonverbindungen als calcilytica | |
| DK1670743T3 (da) | Fremgangsmåde til fremstilling af optisk rene 2-(4-hydroxyphenoxy)propansyre-forbindelser | |
| DK2265580T3 (da) | Hidtil ukendt fremgangsmåde til fremstillingen af sulfonylpyrroler som HDAC-inhibitorer | |
| DK1745140T3 (da) | Biotransformation af colchicinoidforbindelser | |
| DK1581504T3 (da) | Fremgangsmåde til fremstilling af subsituterede imidazolderivater og intermediater anvendt i fremgangsmåden |